Clinical Trials on Porokeratosis, Disseminated Superficial Actinic in Poland
Total 0 results
Nothing found
Sponsors and Collaborators
- Midlothian Care Center
- Evolve BioSystems, Inc.
- No.2 People Hospital of Fuyang City
- Kolfarma s.r.l. - Italy
- BioSensics LLC
- Penza State University
- Ramboll Group
- Forschungsverbund Rehabilitationswissenschaften Sachsen-Anhalt
- National University Polyclinics, Singapore
- Crovelis
- The University of Texas System Healthcare Safety & Effectiveness Grants Program
- Xiyuan Hospital of China Academy of Chinese Medical Sciences
- Universal Biosensors Pty Ltd
- Dr Jérôme Rambaud, MD, PhD; Sorbonne University, Paris, France
- Siddhartha Ganguly
- Alfred Benzon Foundation
- University of Houston
- IRCCS-Istituto delle scienze neurologiche di Bologna
- MITERA Children's Hospital
- CirQuest Labs
- View Full List
Medical Conditions
- Severe Haemophilia A
- Stimulant Use (Diagnosis)
- Five-year Survival Rate
- Germinal Center B-cell Type (GCB)
- Tumor, Benign
- Attention Deficit Hyperactivity Disorder Symptoms
- Heart Failure With Reduced Ejection Fraction (HFrEF)
- FIGO Stage III Primary Peritoneal Cancer
- Benign Lymphoproliferative Disorder
- To Analyze the Frequency of Posttraumatic Stress Disorder in Cases With Awareness and Possible Awareness
- Associated Conditions
- Lack of Drug Action
- Acute Myocardial Infraction or Chest Pain
- Maxillary Deficiency
- Spondylitis Secondary to Inflammatory Bowel Disease
- Disorder of Nipple
- Intramural Haematoma of Thoracic Aorta
- Periprosthetic Fracture of the Upper or Lower Limb
- Focal Cortical Dysplasia
- Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)
- View Full List
Drug Interventions
- Etrumadenant
- ECx1
- RVX000222
- BAY1902607
- 0.2 mg/kg of oxycodone
- Oseltamivir and chinese medicinal herbs
- Palbociclib
- EE 20 microgram with drospirenone 3 mg
- Total intravenous anesthesia with propofol
- IV methylprednisolone
- Insulin Glargine
- Insulin degludec
- I-131-CLR1404 Injection
- Ivacaftor
- MT-1303-FormB
- Cisplatin
- ZPL-3893787
- Digoxin
- OSI-930 and erlotinib
- NBT-NM108
- View Full List
CROs by country
- Contract Research Organizations in Australia
- Contract Research Organizations in Bulgaria
- Contract Research Organizations in Guatemala
- Contract Research Organizations in Guinea
- Contract Research Organizations in Iran
- Contract Research Organizations in Israel
- Contract Research Organizations in Saint Lucia
- Contract Research Organizations in Senegal
- Contract Research Organizations in Trinidad & Tobago
- Contract Research Organizations in Uganda
- Contract Research Organizations in Uruguay
- Contract Research Organizations in Venezuela
- Contract Research Organizations in Zambia
- CRO list by country